Generian Pharmaceuticals
PrivateLast Round
Seed
Oct 1, 2019
Total Funding Raised
$13M
Company Overview
Generian Pharmaceuticals operates in Healthcare & Life Sciences and is based in Pittsburgh, Pennsylvania. Its latest recorded funding round was a Seed round in October 2019.
Generian Pharmaceuticals is a preclinical biotechnology company that discovers and develops orally available small molecule therapeutics for diseases with high unmet needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Generian Pharmaceuticals Comparables
Compare Generian Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dunad Therapeutics | 84% | |
| E3 Therapeutics Inc. | 83% | |
| Talus Bio | 82% |
For institutional investors. Book with your work email.
Generian Pharmaceuticals Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Generian Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Pittsburgh Innovation Institute | Seed |
| UPMC Enterprises | Seed |
Generian Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Generian Pharmaceuticals's valuation, stock price, and market status.
Is Generian Pharmaceuticals a public or private company?
Generian Pharmaceuticals is a private company.
What is the current stock price of Generian Pharmaceuticals?
Generian Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Generian Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Generian Pharmaceuticals worth (valuation)?
Valuation information for Generian Pharmaceuticals is not publicly available.
Can I buy Generian Pharmaceuticals stock?
Generian Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Generian Pharmaceuticals's last funding round?
Generian Pharmaceuticals's most recent funding round was Seed on October 1, 2019.
Who are the main investors in Generian Pharmaceuticals?
Key investors in Generian Pharmaceuticals include UPMC Enterprises.
Will Generian Pharmaceuticals IPO soon?
No public IPO plans have been announced for Generian Pharmaceuticals.
How can I track Generian Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Generian Pharmaceuticals's shares on secondary markets.